HOME
DONATE Beneficiaries Past Events Proud Supporters
Related Articles
Welcome! You are invited to join a meeting: B Informed: Liver Cancer – Working Together to Tell a New Story. After registering, you will receive a confirmation email about joining the meeting.
Welcome! You are invited to join a meeting: B Informed: Liver Cancer – Working Together to Tell a New Story. After registering, you will receive…
Program Guide – ASCO Meeting Program Guide
Marcia Brose Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University Hospital, Philadelphia, PA Marcia Brose, Maria Cabanillas, Jessica Lin, Raymond McDermott, Mohammed…
Program Guide – ASCO Meeting Program Guide
Amy Shaver Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA Amy Shaver, Kevin Zarrabi, Nikita Nikita, William Kelly, Grace Lu-Yao Department of Medical Oncology,…
3D-Printed Organ-Realistic Phantoms to Verify Quantitative SPECT/CT Accuracy for 177Lu-PSMA-617 Treatment Planning
Background/Objectives: Accurate patient-specific dosimetry is essential for optimizing radiopharmaceutical therapy (RPT), but current tools lack validation in clinically realistic conditions. This work aimed to develop…
Community Learning and Experience About Research’ Program Connects Community Members with Sidney Kimmel Comprehensive Cancer Center Researchers | Jefferson Health
The program gives individuals a look into the laboratory & provides insight to researchers from our community’s perspective
Focus | Innovative Cancer Care | Elekta
Explore cutting-edge cancer treatment and healthcare innovations in Focus, Elekta’s Online Magazine. Stay informed with the latest articles. Discover more.
66th ASH Annual Meeting: 613. Acute Lymphoblastic Leukemias: Therapies Excluding Allogeneic Transplantation: Clinical Trials in Pediatric and Young Adult Patients
Lindsay Wilde, MD, Thomas Jefferson University and Joanna S. Yi, MD, Baylor College of Medicine/Texas Children’s
Paper: Health-Related Quality of Life in Patients with Relapsed/Refractory Cutaneous T-Cell Lymphoma Treated By Lacutamab: Patient-Reported Outcomes from the Phase 2 Tellomak Trial
Program: Oral and Poster Abstracts Type: Oral Session: 625. T Cell, NK Cell, or NK/T Cell Lymphomas: Clinical and Epidemiological: When Old Meets New in…
66th ASH Annual Meeting: Blood Drop: Translational Research Training in Hematology (TRTH) Program
Sara E. Meyer, PhD, Thomas Jefferson University, Sidney Kimmel Comprehensive Can cer Center Meyer: CellCentric: Research Funding. Learn about what the ASH-EHA Translational Research Training…
Studying Anti-MDM2 PROTAC May Yield New Modality in p53-Mutated Cancer
Further optimizing a PROTAC that targets MDM2 may lead to human clinical trials among patients with cancer harboring p53 mutations.